12/4
11:51 am
sion
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says [Yahoo! Finance]
Low
Report
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says [Yahoo! Finance]
12/1
08:45 am
sion
Sionna Therapeutics (NASDAQ:SION) had its "underperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $24.00 price target on the stock.
Medium
Report
Sionna Therapeutics (NASDAQ:SION) had its "underperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $24.00 price target on the stock.
11/24
07:00 am
sion
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
Low
Report
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
11/20
01:39 pm
sion
Sionna Therapeutics (NASDAQ:SION) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sionna Therapeutics (NASDAQ:SION) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
06:03 am
sion
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
11/19
08:07 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at BTIG Research. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at BTIG Research. They set a "buy" rating and a $50.00 price target on the stock.
11/15
01:42 am
sion
Sionna Therapeutics (NASDAQ:SION) was downgraded by analysts at
Wall Str
Medium
Report
Sionna Therapeutics (NASDAQ:SION) was downgraded by analysts at
Wall Str
11/14
09:00 am
sion
The NEVYs 2025 Nominees Revealed: New England's Innovation Leaders Take Center Stage
Medium
Report
The NEVYs 2025 Nominees Revealed: New England's Innovation Leaders Take Center Stage
11/7
08:40 am
sion
Sionna Therapeutics (SION): Assessing Valuation After a Rapid 95% 3-Month Share Price Surge [Yahoo! Finance]
Low
Report
Sionna Therapeutics (SION): Assessing Valuation After a Rapid 95% 3-Month Share Price Surge [Yahoo! Finance]
11/5
02:04 pm
sion
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/5
07:49 am
sion
Sionna Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Low
Report
Sionna Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/5
07:00 am
sion
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
Low
Report
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
11/4
08:00 am
sion
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
Low
Report
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
10/24
01:15 pm
sion
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
Low
Report
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
10/21
07:00 am
sion
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
High
Report
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
10/8
12:35 pm
sion
Sionna Therapeutics (NASDAQ:SION) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sionna Therapeutics (NASDAQ:SION) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
05:20 pm
sion
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference [Yahoo! Finance]
Low
Report
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference [Yahoo! Finance]
10/1
04:05 pm
sion
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
Low
Report
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
9/15
01:56 pm
sion
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy [Yahoo! Finance]
9/8
12:38 pm
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Jones Trading. They set a "buy" rating and a $46.00 price target on the stock.
Medium
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Jones Trading. They set a "buy" rating and a $46.00 price target on the stock.
9/8
08:15 am
sion
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer [Yahoo! Finance]
Medium
Report
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer [Yahoo! Finance]
9/8
08:00 am
sion
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
Medium
Report
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer